4//SEC Filing
Dunne Michael W. 4
Accession 0001209191-23-001287
CIK 0001659323other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 6:00 PM ET
Size
7.5 KB
Accession
0001209191-23-001287
Insider Transaction Report
Form 4
Dunne Michael W.
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2023-01-01+761→ 36,337 total - Exercise/Conversion
Restricted Share Units
2023-01-01−761→ 0 totalExercise: $0.00→ Ordinary Shares (761 underlying)
Footnotes (3)
- [F1]Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
- [F2]On March 25, 2022, the reporting person was granted an award of 11,426 RSUs (the "RSU Grant"), which vested on January 1, 2023.
- [F3]On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares underlying the RSU Grant have been adjusted to reflect the Reverse Share Split.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001553593
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 6:00 PM ET
- Size
- 7.5 KB